share_log

Here's Why Hygeia Healthcare Holdings (HKG:6078) Can Manage Its Debt Responsibly

Here's Why Hygeia Healthcare Holdings (HKG:6078) Can Manage Its Debt Responsibly

這就是Hygeia Healthcare Holdings(HKG: 6078)可以負責任地管理債務的原因
Simply Wall St ·  05/03 18:36

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. Importantly, Hygeia Healthcare Holdings Co., Limited (HKG:6078) does carry debt. But should shareholders be worried about its use of debt?

有人說,波動性,而不是債務,是投資者思考風險的最佳方式,但禾倫·巴菲特曾說過一句名言:“波動性遠非風險的代名詞。”當你檢查公司的資產負債表的風險時,考慮它的資產負債表是很自然的,因爲企業倒閉時通常會涉及債務。重要的是,Hygeia Healthcare Holdings Co., Limited(HKG: 6078)確實有債務。但是,股東是否應該擔心其債務的使用?

When Is Debt A Problem?

債務何時會成爲問題?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. If things get really bad, the lenders can take control of the business. However, a more common (but still painful) scenario is that it has to raise new equity capital at a low price, thus permanently diluting shareholders. By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. The first step when considering a company's debt levels is to consider its cash and debt together.

當企業無法輕易履行這些義務時,無論是通過自由現金流還是以誘人的價格籌集資金,債務和其他負債就會面臨風險。如果情況變得非常糟糕,貸款人可以控制業務。但是,更常見(但仍然令人痛苦)的情況是,它必須以低廉的價格籌集新的股權資本,從而永久稀釋股東。但是,通過取代稀釋,債務可以成爲需要資本以高回報率投資增長的企業的一個非常好的工具。考慮公司債務水平的第一步是將其現金和債務放在一起考慮。

What Is Hygeia Healthcare Holdings's Debt?

Hygeia Healthcare Holdings的債務是多少?

You can click the graphic below for the historical numbers, but it shows that as of December 2023 Hygeia Healthcare Holdings had CN¥2.72b of debt, an increase on CN¥1.28b, over one year. On the flip side, it has CN¥755.9m in cash leading to net debt of about CN¥1.97b.

你可以點擊下圖查看歷史數字,但它顯示,截至2023年12月,Hygeia Healthcare Holdings在一年內有27.2億元人民幣的債務,比12.8億元人民幣有所增加。另一方面,它擁有7.559億元的現金,淨負債約爲19.7億元人民幣。

debt-equity-history-analysis
SEHK:6078 Debt to Equity History May 3rd 2024
SEHK: 6078 2024 年 5 月 3 日債務與股本的比率記錄

A Look At Hygeia Healthcare Holdings' Liabilities

看看 Hygeia Healthcare Holdings 的負債

Zooming in on the latest balance sheet data, we can see that Hygeia Healthcare Holdings had liabilities of CN¥1.94b due within 12 months and liabilities of CN¥2.54b due beyond that. Offsetting this, it had CN¥755.9m in cash and CN¥912.3m in receivables that were due within 12 months. So it has liabilities totalling CN¥2.81b more than its cash and near-term receivables, combined.

放大最新的資產負債表數據,我們可以看到,Hygeia Healthcare Holdings在12個月內到期的負債爲19.4億元人民幣,之後到期的負債爲25.4億元人民幣。與此相抵消的是,它有7.559億元的現金和9.123億元人民幣的應收賬款將在12個月內到期。因此,它的負債總額爲28.1億元人民幣,比現金和短期應收賬款的總和還要多。

Since publicly traded Hygeia Healthcare Holdings shares are worth a total of CN¥21.2b, it seems unlikely that this level of liabilities would be a major threat. But there are sufficient liabilities that we would certainly recommend shareholders continue to monitor the balance sheet, going forward.

由於公開交易的Hygeia Healthcare Holdings股票總價值爲212億元人民幣,因此這種負債水平似乎不太可能構成重大威脅。但是,有足夠的負債,我們肯定會建議股東今後繼續監督資產負債表。

We use two main ratios to inform us about debt levels relative to earnings. The first is net debt divided by earnings before interest, tax, depreciation, and amortization (EBITDA), while the second is how many times its earnings before interest and tax (EBIT) covers its interest expense (or its interest cover, for short). The advantage of this approach is that we take into account both the absolute quantum of debt (with net debt to EBITDA) and the actual interest expenses associated with that debt (with its interest cover ratio).

我們使用兩個主要比率來告知我們相對於收益的債務水平。第一個是淨負債除以利息、稅項、折舊和攤銷前的收益(EBITDA),第二個是其利息和稅前收益(EBIT)覆蓋其利息支出(或簡稱利息保障)的多少倍。這種方法的優勢在於,我們既考慮了債務的絕對數量(包括淨負債與息稅折舊攤銷前利潤),也考慮了與該債務相關的實際利息支出(及其利息覆蓋率)。

Hygeia Healthcare Holdings's net debt to EBITDA ratio of about 1.9 suggests only moderate use of debt. And its commanding EBIT of 26.4 times its interest expense, implies the debt load is as light as a peacock feather. One way Hygeia Healthcare Holdings could vanquish its debt would be if it stops borrowing more but continues to grow EBIT at around 18%, as it did over the last year. There's no doubt that we learn most about debt from the balance sheet. But it is future earnings, more than anything, that will determine Hygeia Healthcare Holdings's ability to maintain a healthy balance sheet going forward. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

Hygeia Healthcare Holdings的淨負債與息稅折舊攤銷前利潤的比率約爲1.9,這表明債務的使用量不大其驚人的息稅前利潤是利息支出的26.4倍,這意味着債務負擔像孔雀羽毛一樣輕。Hygeia Healthcare Holdings克服債務的一種方法是停止增加借款,但繼續像去年一樣將息稅前利潤增長至18%左右。毫無疑問,我們從資產負債表中學到的關於債務的知識最多。但是,未來的收益將決定Hygeia Healthcare Holdings未來維持健康資產負債表的能力。因此,如果您專注於未來,可以查看這份顯示分析師利潤預測的免費報告。

Finally, while the tax-man may adore accounting profits, lenders only accept cold hard cash. So we clearly need to look at whether that EBIT is leading to corresponding free cash flow. Over the last three years, Hygeia Healthcare Holdings recorded negative free cash flow, in total. Debt is usually more expensive, and almost always more risky in the hands of a company with negative free cash flow. Shareholders ought to hope for an improvement.

最後,儘管稅務人員可能喜歡會計利潤,但貸款人只接受冷硬現金。因此,我們顯然需要研究息稅前利潤是否會帶來相應的自由現金流。在過去的三年中,Hygeia Healthcare Holdings的總自由現金流爲負。債務通常更昂貴,而且對於自由現金流爲負的公司來說,風險幾乎總是更大。股東們應該希望有所改善。

Our View

我們的觀點

On our analysis Hygeia Healthcare Holdings's interest cover should signal that it won't have too much trouble with its debt. But the other factors we noted above weren't so encouraging. In particular, conversion of EBIT to free cash flow gives us cold feet. We would also note that Healthcare industry companies like Hygeia Healthcare Holdings commonly do use debt without problems. When we consider all the elements mentioned above, it seems to us that Hygeia Healthcare Holdings is managing its debt quite well. But a word of caution: we think debt levels are high enough to justify ongoing monitoring. Of course, we wouldn't say no to the extra confidence that we'd gain if we knew that Hygeia Healthcare Holdings insiders have been buying shares: if you're on the same wavelength, you can find out if insiders are buying by clicking this link.

根據我們的分析,Hygeia Healthcare Holdings的利息保障應該表明其債務不會遇到太多問題。但是我們上面提到的其他因素並不那麼令人鼓舞。特別是,將息稅前利潤轉換爲自由現金流使我們措手不及。我們還要指出,像Hygeia Healthcare Holdings這樣的醫療保健行業公司通常會毫無問題地使用債務。當我們考慮上述所有因素時,在我們看來,Hygeia Healthcare Holdings的債務管理得很好。但要謹慎一點:我們認爲債務水平足夠高,足以證明持續監測是合理的。當然,我們不會對如果我們知道Hygeia Healthcare Holdings的內部人士一直在購買股票所獲得的額外信心說不:如果你持同樣的看法,你可以通過點擊這個鏈接來了解內部人士是否在買入。

If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.

畢竟,如果你對一家資產負債表堅如磐石的快速成長型公司更感興趣,那麼請立即查看我們的淨現金增長股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論